Allogene Therapeutics, Inc. (ALLO) vs NeoGenomics, Inc. (NEO)
A side-by-side comparison of Allogene Therapeutics, Inc. and NeoGenomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
NEO
NeoGenomics, Inc.
$19.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALLO vs NEO
growth of $100 · dividends reinvested · last 8yALLO -94.0% (-29.6%/yr)NEO +34.7% (+3.8%/yr)NEO compounded faster over this window
Log scale — wide-divergence pair
ALLO NEO
ALLO vs NEO: by the numbers
- •ALLO is the larger company ($518M vs $492M market cap).
- •Both run net losses; NEO's is the smaller (-6.77% vs -3566.68% net margin).
- •NEO grew revenue faster over the past five years (9.41% vs -34.47% CAGR).
Metrics side by side
Valuation
| Metric | ALLO | NEO |
|---|---|---|
| Forward P/E | N/A | 104.69 |
| P/S ratio | 111.58 | 0.64 |
| P/B ratio | 1.19 | 0.63 |
Profitability
| Metric | ALLO | NEO |
|---|---|---|
| Gross margin | 0.00% | 42.92% |
| Operating margin | 0.00% | -8.63% |
| Net margin | -3566.68% | -6.77% |
| ROE | -37.94% | -6.60% |
| ROIC | -34.79% | -5.29% |
Growth (annualized)
| Metric | ALLO | NEO |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | 9.41% |
| Total return CAGR (5Y) | -42.72% | -15.14% |
Frequently asked
- Which has grown faster, ALLO or NEO?
- Over the past five years, NEO grew revenue faster — ALLO at a -34.47% CAGR versus NEO at 9.41%.
- How have ALLO and NEO total returns compared?
- Over the past 5 years, ALLO delivered -42.72% and NEO delivered -15.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.